Oncology

Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong

Advancing Women’s Health: Project Teal drives cervical cancer screening in Hong Kong

  To find out more about the Karen Leung Foundation and the work they do, please click here. In Hong Kong, cervical cancer ranked as the 8th most common cancer and cause of mortality amongst women in 2019 [1]. Despite a national screening programme implemented in 2004, studies show that close to 40% of women […]

Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong Read More »

APEC policy dialogue on cervical cancer management highlights role of clinical labs

APEC policy dialogue on cervical cancer management highlights role of clinical labs

This article is part of a series on diagnostics within Women’s Health. We’ll be adding more stories and related content throughout the year. Check out the first story in this series about cervical cancer triage testing here.  On Jan 28, cervical cancer experts from across the Asia Pacific region and around the world came together

APEC policy dialogue on cervical cancer management highlights role of clinical labs Read More »

HER2 DISH assay showcases value of image analysis algorithms

HER2 DISH assay showcases values of image analysis algorithms

Compared to traditional immunohistochemistry (IHC) and protein staining techniques, many pathologists prefer bright-field chromogenic or silver-enhanced in situ hybridization (ISH) staining more than fluorescence ISH, because it provides more stable results that can be reviewed over time without fears of degradation. In a recent webinar hosted by Roche Diagnostics Asia Pacific, two Australian pathologists discussed

HER2 DISH assay showcases value of image analysis algorithms Read More »

For breast cancer analysis, digital pathology offers a streamlined approach

For breast cancer analysis, digital pathology offers a streamlined approach

Of the many specialty areas for which clinical labs are implementing digital pathology, breast cancer is among the most common — and one of the applications where digital pathology has been the most helpful. The ability to perform whole-slide imaging has been valuable for samples with highly heterogeneous tissue and in light of the increasing

For breast cancer analysis, digital pathology offers a streamlined approach Read More »

Advancing women’s health: p16/Ki-67 dual staining technology improves cervical cancer diagnostics

Advancing women’s health: p16/Ki-67 dual staining technology improves cervical cancer diagnostics

To learn more about how cervical cancer impacts the lives of women globally and the steps organisations are taking to eliminate this disease globally, please visit the Conquering Cancer campaign. Click here for videos related to the campaign.  This article is part of a new series on diagnostics within Women’s Health. We’ll be adding more

Advancing women’s health: p16/Ki-67 dual staining technology improves cervical cancer diagnostics Read More »

‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)

‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)

In 2019, Dr Thomas Grogan published Chasing the Invisible, a memoir about his experience in launching, scaling and selling Ventana Medical Systems, a pioneer and leading provider of automated instruments for tissue diagnosis. In the third instalment of this three-part series on Dr Grogan’s life and career, we explore some of the key lessons from

‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3) Read More »

Scaling and selling a tissue diagnostics startup: Q&A with Dr Thomas Grogan (Part 2)

Scaling and selling a tissue diagnostics startup: Q&A with Dr Thomas Grogan (Part 2)

After launching Ventana Medical Systems as a spinout from the University of Arizona, Dr Thomas Grogan played a central role in building the company from a scrappy startup into a leading provider of automated instruments for tissue biopsies and cancer diagnostics. In the second instalment of this three-part series on Dr Grogan’s life and career,

Scaling and selling a tissue diagnostics startup: Q&A with Dr Thomas Grogan (Part 2) Read More »

The founding of Ventana Medical Systems: Q&A with Dr Thomas Grogan (Part 1)

The founding of Ventana Medical Systems: Q&A with Dr Thomas Grogan (Part 1)

As the founder of Ventana Medical Systems, a medical technology firm that pioneered the use of automation technologies for tissue diagnostics, Dr Thomas Grogan helped drive many important advances in cancer care In the first instalment of this three-part series on Dr Grogan’s life and career, we hear about the formative experiences that led him

The founding of Ventana Medical Systems: Q&A with Dr Thomas Grogan (Part 1) Read More »

Virtual Reference Site Visit: Taipei Veterans General Hospital (RED 2021)

Virtual Reference Site Visit: Taipei Veterans General Hospital

Taipei Veterans General Hospital (VGH-TPE) is a national first-class medical centre in Taiwan with the ambition to impact the healthcare industry by leveraging innovation. This session will focus on how VGH-TPE (a) introduces new technology solutions to improve patient experience; (b) changes the way of disease management for better patient outcome; and (iii) embrace new

Virtual Reference Site Visit: Taipei Veterans General Hospital (RED 2021) Read More »

Hearing the patient voice in breast cancer: Ms Noren Suseno on her journey from diagnosis to recovery (RED 2021)

Hearing the patient voice in breast cancer: Ms Noren Suseno on her journey from diagnosis to recovery (RED 2021)

Hear from Ms Noren Suseno, a breast cancer survivor and member of the Breast Cancer Foundation, Singapore, as she shares her journey from diagnosis to treatment and recovery. Ms Suseno also talks about the work that the Foundation provides for its members, including their efforts to improve early breast cancer detection and support for the

Hearing the patient voice in breast cancer: Ms Noren Suseno on her journey from diagnosis to recovery (RED 2021) Read More »

Scroll to Top